or
Looking to list your PhD opportunities? Log in here.
Glioblastoma is a deadly brain tumour treated with surgery, radiotherapy and chemotherapy with patient survival of 6-15 months. Our previous work investigated changes in the microenvironment of glioblastoma tumours that have become resistant to radiotherapy, using patient samples and an in vivo model of glioblastoma recurrence following radiotherapy. We found vascular changes in recurrent tumours that elevate hypoxia, thus promoting invasiveness to the normal brain and resistance to further treatment. RNA sequencing revealed upregulation of ligands that activate Wnt signaling, associated with altered blood vessel morphology and function. During normal development Wnt ligands bind Frizzled and other receptors to control gene transcription, proliferation and differentiation. Deregulation of Wnt signaling in cancer cells, or the tumour microenvironment (immune cells, fibroblasts, blood vessels) is associated with malignancy. Our aim is to understand the role of Wnt ligands in glioblastoma recurrence using knockdown and overexpression approaches employing 3-dimensional culture and in vivo recurrence models established in our lab. Furthermore, we will analyze differential ligand expression in patient samples of primary and recurrent glioblastoma tumours (paired). We will assess the efficacy of Wnt inhibitors in combination with radiotherapy, aiming to improve response to radiotherapy and survival of patients with recurrent glioblastoma.
Techniques associated with this project:
The student will gain experience in a wide range of techniques and approaches including CRISPR, western blotting, RNA sequencing, culture model of perfused endothelial tubes in microfluidic devices, in vivo model of radiotherapy treatment, confocal imaging, immunohistochemical and immunofluorescence analysis of patient samples, Image J software analysis.
This project is part of the International PhD Academy: Medical Research
Eligibility:
You should hold a first degree equivalent to at least a UK upper second class honours degree in a relevant subject.
Candidates whose first language is not English must provide evidence that their English language is sufficient to meet the specific demands of their study. The Faculty of Medicine and Health minimum requirements are:
How to apply:
Applications can be made at any time. To apply for this project applicants should complete an online application form and attach the following documentation to support their application.
To help us identify that you are applying for this project please ensure you provide the following information on your application form;
Any queries regarding the application process should be directed to fmhpgradmissions@leeds.ac.uk
The university will respond to you directly. You will have a FindAPhD account to view your sent enquiries and receive email alerts with new PhD opportunities and guidance to help you choose the right programme.
Log in to save time sending your enquiry and view previously sent enquiries
The information you submit to University of Leeds will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Leeds, United Kingdom
Start a New search with our database of over 4,000 PhDs
Based on your current search criteria we thought you might be interested in these.
Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer
University of Bradford
The role of vitamin D3 in treating skin cancer and preventing drug resistance
University of Bradford
Studying of cancer biology with doped magnetic nanomaterials to unravelling their thermal therapeutic potentials
University College London